rediff.com
e.g. Tata motors, Reliance MF, 500570
Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 25.46 25.46 25.46 25.46 12.73
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 2,030.44 1,723.92 1,495.24 1,039.73 770.10
Loan funds
Secured loans 38.58 69.16 95.57 141.23 185.29
Unsecured loans - - - - -
Total 2,094.47 1,818.54 1,616.27 1,206.41 968.12
Uses of funds
Fixed assets
Gross block 758.92 710.83 692.04 567.38 455.66
Less : revaluation reserve - - - - -
Less : accumulated depreciation 235.38 198.80 157.84 126.22 98.92
Net block 523.54 512.03 534.19 441.16 356.74
Capital work-in-progress 179.08 164.81 29.99 96.32 101.71
Investments 1,084.66 710.06 599.90 426.24 276.32
Net current assets
Current assets, loans & advances 453.43 571.43 640.81 395.11 376.11
Less : current liabilities & provisions 146.24 139.79 188.62 152.42 142.76
Total net current assets 307.19 431.64 452.18 242.69 233.35
Miscellaneous expenses not written - - - - -
Total 2,094.47 1,818.54 1,616.27 1,206.41 968.12
Notes:
Book value of unquoted investments 317.21 710.06 599.90 426.24 276.32
Market value of quoted investments 767.45 - - - -
Contingent liabilities 56.30 190.84 29.38 47.70 78.83
Number of equity sharesoutstanding (Lacs) 2545.65 2545.65 2545.65 2545.65 1272.82
Close
Add Suven Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Suven Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close